Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18223031 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Rosiglitazone;   Drug: glyburide;   Drug: metformin

Indicates status has not been verified in more than two years